CSIMarket
 
Nutriband Inc   (NASDAQ: NTRB)
 

Nutriband Inc's Customers Performance

NTRB



 
NTRB's Source of Revenues During the corresponding time, Nutriband Inc saw a revenue deteriorated by -29.71 % year on year, sequentially revenue grew by 0.95 %. While revenue at the Nutriband Inc 's corporate clients

List of NTRB Customers




for the same period Nutriband Inc revnue deteriorated by -29.71 % year on year, sequentially revenue grew by 0.95 %.

List of NTRB Customers

Nutriband Inc's Business Units
Reportable Subsegments    198.86 % of total Revenue
Sale of goods    100 % of total Revenue
US    100 % of total Revenue






Nutriband Inc's Comment on Sales, Marketing and Customers



4P Therapeutics is a contract research and development company serving pharmaceutical and medical device clients, primarily in the United States. Their lead product is AVERSA™ Fentanyl, an abuse-deterrent fentanyl transdermal system developed in collaboration with Kindeva Drug Delivery, a global contract development and manufacturing organization. The company has expanded its pipeline to include AVERSA™ Buprenorphine and AVERSA™ Methylphenidate and focuses on developing transdermal pharmaceutical products to enhance drug delivery. 4P Therapeutics has engaged with the FDA for feedback on AVERSA™ Fentanyl and established an exclusive product development partnership with Kindeva based on shared development costs and milestone payments. Other entities mentioned in filings include 3M Drug Delivery, Nutriband, and Pocono Pharmaceuticals.





Nutriband Inc’s Comment on Sales, Marketing and Customers


4P Therapeutics is a contract research and development company serving pharmaceutical and medical device clients, primarily in the United States. Their lead product is AVERSA™ Fentanyl, an abuse-deterrent fentanyl transdermal system developed in collaboration with Kindeva Drug Delivery, a global contract development and manufacturing organization. The company has expanded its pipeline to include AVERSA™ Buprenorphine and AVERSA™ Methylphenidate and focuses on developing transdermal pharmaceutical products to enhance drug delivery. 4P Therapeutics has engaged with the FDA for feedback on AVERSA™ Fentanyl and established an exclusive product development partnership with Kindeva based on shared development costs and milestone payments. Other entities mentioned in filings include 3M Drug Delivery, Nutriband, and Pocono Pharmaceuticals.








NTRB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Nutriband Inc 85.58 1.62 -6.96 5
SUBTOTAL 0.00 0.00 0.00 -

Sources: Nutriband Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Nutriband Inc’s corporate clients.
For your research, we’ve provided 9 tables on Nutriband Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.